CIK 0002010788 · <br>Emerging growth company
EXOZYMES INC.
Sign in to watch- Ticker
- EXOZ
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 834550057
- Phone
- (626) - 415 - 1488
- Business address
- 750 ROYAL OAKS DR, MONROVIA, CA, 91016
- Former names
- Invizyne Technologies Inc
- 424B5 Offering Prospectus
- 8-K Event Regulation FD disclosure
- 8-K Event Material agreement · Regulation FD disclosure
- 8-K Event Material agreement · Regulation FD disclosure
- 424B5 Offering Prospectus
- 424B5 Offering Prospectus
- 424B5 Offering Prospectus
- 10-Q Report Quarterly Report
- 8-K Event Other events
- 8-K Event Other events
- 4 Open-market sale Chief Scientific Officer sold 1,500 shares at an average $10.28 ($15,424)
- 424B5 Offering Prospectus
- 4 Grant or award Chief Commercial Officer acquired 62,759 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Chief Commercial Officer acquired 8,887 shares (grant or award)
- 4 Grant or award Vice President, Development acquired 3,999 shares (grant or award)
- 4 Grant or award Vice President- Finance acquired 5,999 shares (grant or award)
- 4 Grant or award Chief Scientific Officer acquired 5,332 shares (grant or award)
- 8-K Event Other events
- 10-K Report Annual Report
Page 2 of 7 · 130 filings